Cetera Advisors LLC
- SEC CIK
- 0001534400
- Latest filing
- May 24, 2024
NKTR holding history
Nektar Therapeutics in every 13F filed by Cetera Advisors LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
NKTR overviewAll 13F holders of NKTRFull Q1 2024 holdings
- Shares (Q1 2024)
- 0
- Sold out in Q1 2024
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 9
- Since Q4 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2024 | 0 | $0 | 0.0% | −12,300−100.0% | Sold out | Holders |
| Q4 2023 | 12,300 | $6.95K | <0.1% | −400−3.1% | Reduced | Holders |
| Q3 2023 | 12,700 | $7.56K | <0.1% | −4,580−26.5% | Reduced | Holders |
| Q2 2023 | 17,280 | $9.94K | <0.1% | −75−0.4% | Reduced | Holders |
| Q1 2023 | 17,355 | $12.2K | <0.1% | −600−3.3% | Reduced | Holders |
| Q4 2022 | 17,955 | $40.6K | <0.1% | −300−1.6% | Reduced | Holders |
| Q3 2022 | 18,255 | $58.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2022 | 18,255 | $69.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2022 | 18,255 | $98.0K | <0.1% | +3,125+20.7% | Added | Holders |
| Q4 2021 | 15,130 | $204.0K | <0.1% | +15,130 | New | Holders |